Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 43)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
24-Nov-09 New Constructs, LLC N/A IDXX: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
24-Nov-09 ValuEngine, Inc. N/A ValuEngine Industry Report for MEDICAL SUPPLIES 18 $49 View Abstract
24-Nov-09 Stock Traders Daily Thomas H. Kee Jr. Trading Report for (IDXX). A detailed Technical Analysis + Trading Plans for Day Trading, Swing Trading, and Long Term proactive investments in (IDXX). 5 $18 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
23-Nov-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for IDXX 13 $25 View Abstract
23-Nov-09 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
Next 20

Brokerage Reports (Showing 1 to 2 of 2)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
23-Oct-09 Thomson StreetEvents N/A IDXX - Event Transcript of Idexx Laboratories conference call, Oct. 23, 2009 / 9:00am ET 19 $75 View Abstract
23-Oct-09 Thomson StreetEvents N/A IDXX - Event Brief of Idexx Laboratories conference call, Oct. 23, 2009 / 9:00am ET 20 $75 View Abstract

Independent Reports (Showing 1 to 10 of 41)

Release
Date Contributor Author Title Pages Price More Info
24-Nov-09 New Constructs, LLC N/A IDXX: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
24-Nov-09 ValuEngine, Inc. N/A ValuEngine Industry Report for MEDICAL SUPPLIES 18 $49 View Abstract
24-Nov-09 Stock Traders Daily Thomas H. Kee Jr. Trading Report for (IDXX). A detailed Technical Analysis + Trading Plans for Day Trading, Swing Trading, and Long Term proactive investments in (IDXX). 5 $18 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
23-Nov-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for IDXX 13 $25 View Abstract
23-Nov-09 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.